北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION
作者: Zhu, J.1; Huang, H.2; Chen, H.3; Zhang, X.4; Li, Z.5,6; Wu, D.7; Zhou, D.8; Song, Y.9; Hu, Y.10; Liang, Y.11; Ren, H.12; Huang, H.13; Li, N.14; Chen, H.15; Hu, J.16; Li, J.17; Meng, R.18; Ge, J.18; Wu, J.19; Huang, X.3
刊名: HAEMATOLOGICA
发表日期: 2015-06-01
卷: suppl.1, 页:284-284
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Hematology
研究领域[WOS]: Hematology
语种: 英语
WOS记录号: WOS:000361204902223
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/67235
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Soochaw Univ, Affiliated Hosp 1, Suzhou, Peoples R China
2.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
3.307 Hosp PLA, Beijing, Peoples R China
4.Shanghai Ruijin Hosp, Shanghai, Peoples R China
5.Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
6.Sanofi R&D, Shanghai, Peoples R China
7.Sanofi R&D, Beijing, Peoples R China
8.Beijing Canc Hosp, Beijing, Peoples R China
9.Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
10.Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
11.CAMS, Inst Hematol, Tianjin, Peoples R China
12.CAMS, Hosp Blood Dis, Tianjin, Peoples R China
13.Beijing Union Med Coll Hosp, Beijing, Peoples R China
14.Huazhong Univ Sci Technol, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China
15.Mil Med Univ, Tangdu Hosp, Xian, Shanxi, Peoples R China
16.Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
17.Fujian Med Univ, Affiliated Union Hosp, Fuzhou, Peoples R China
18.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
19.Henan Prov Canc Hosp, Zhengzhou, Henan, Peoples R China

Recommended Citation:
Zhu, J.,Huang, H.,Chen, H.,et al. A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION[J]. HAEMATOLOGICA,2015,suppl.1:284-284.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhu, J.]'s Articles
[Huang, H.]'s Articles
[Chen, H.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhu, J.]‘s Articles
[Huang, H.]‘s Articles
[Chen, H.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace